Thomas N. Konatich
Nessuna posizione attualmente
Profilo
Thomas N.
Konatich was Vice President, Chief Financial Officer and Treasurer of SIGA Technologies, Inc. from April 1, 1998 to January 2009 and Secretary from June 29, 2001 to January 2009.
From 1993 to November 1996, he was Vice President and Chief Financial Officer of Seragen, Inc. From October 5, 2001 to July 2, 2004 and from May 1, 2006 to February 28, 2007, Mr. Konatich was an Acting Chief Executive Officer of SIGA Technologies and Chief Financial Officer and a Director of Innapharma, Inc. from November 1996 to March 1998.
He received an MBA from the Columbia Graduate School of Business.
Precedenti posizioni note di Thomas N. Konatich
| Società | Posizione | Fine |
|---|---|---|
| SIGA TECHNOLOGIES, INC. | Direttore Finanziario/CFO | 31/01/2009 |
Innapharma, Inc. (New York)
 Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996. | Direttore Finanziario/CFO | 01/03/1998 |
Seragen, Inc.
 Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Direttore Finanziario/CFO | 01/11/1996 |
Formazione di Thomas N. Konatich
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Seragen, Inc.
Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Health Technology |
Innapharma, Inc. (New York)
Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996. | Commercial Services |
- Borsa valori
- Insiders
- Thomas N. Konatich
